siRNA therapy decreases triglycerides in individuals with rare condition

.RESEARCH EMPHASIZE.19 September 2024.

Plozasiran minimized triglyceride amounts by 80% as well as lowered the threat of pancreatitis in individuals along with consistent chylomicronemia, with or even without a hereditary medical diagnosis.